Freshstart Medical provides a Next-Generation Sequencing (NGS) solution* that is simple, fast, and affordable — putting the power of NGS technology in the reach of labs of all sizes. The solution is easy-to-use, from automated template preparation and library construction, to sequencing, data analysis and reporting.

The automated solution reduces sample-to-sample variability, minimizes risk of rerun due to user error/inconsistency and help produce more accurate results. With parallel preparation and subsequent analysis of up to 16 sample barcodes, sequencing pipelines are optimized.

The Freshstart Medical NGS platform uses semi-conductor based sequencing technologies to translate chemical signals into meaningful information. Ideal for sequencing targeted regions, the integrated Next-Generation Sequencing (NGS) solution from Freshstart Medical detects single nucleotide variants as well as insertions and deletions.

Several Freshstart Medical’ NGS assays are being developed to identify sequence variants of demonstrated importance, including gene mutations relevant to oncology and viral genotypes, using a variety of sample materials.

Automated data analysis and reporting with Sentosa Reporter turns sophisticated data into concise, clear reports. Open-channel capability is also available, offering users the opportunity to customize and apply user-defined protocols.

Fast Results With Better Patient Outcomes

Freshstart’s breakthrough approach to molecular diagnostics for near-patient testing with the Great Basin platform provides fast, cost-effective diagnosis of infectious diseases. Our easy-to-use assays deliver more diagnostic data per sample, meaning healthcare providers are able to treat patients with the right medication sooner, improving outcomes and reducing costs.

The Great Basin Analyzer is capable of low-plex and multi-plex diagnostics for infectious disease. The system is easy-to-use, freeing up valuable resources and reducing turnaround time for clinicians, thereby providing timely appropriate antibiotic therapy for better patient management, and support of Antimicrobial Stewardship Programs.

The Great Basin system employs an integrated disposable cartridge that contains all necessary reagents, and an inexpensive bench-top analyzer which executes the assay interprets the results and provides electronic output to the clinician.

Flexibly reduce reagent cost and minimize waste through automation

Relevance

Sentosa® FLEX is a Software Solution from Freshstart Medical which enables a new economical approach for PCR workflows. With FLEX, one can be more efficient in carrying routine testing, as well as detecting and monitoring co-infection. FLEX provides multiple choices of assay to sample assignment, while also removing the need for batching. Ultimately FLEX users are able to reduce waste, re-use reagents, avoid batches, while achieving automation and sample traceability.

PURPOSE

Combine up to four assays from the assays selection menu in one run and from one sample, which is the core value of Sentosa®SX FLEX Assistant. In addition, the assistant drastically simplifies laboratory workflow process: from launch to LIS synchronization; from sample to report.

Strategic partnering programs for biomarker and clinical research

Freshstart Medical is always ready to foster long-term relationships with industry counterparts to achieve higher levels of innovation that leverage combined expertise.

By working closely with pharmaceutical and biotechnological companies, Freshstart Medical can provide specialized knowledge in molecular diagnostics and companion diagnostics to help achieve efficiency in pharmaceutical development, regulatory approval and global commercialization.

To reap mutual benefits and rewards, Freshstart Medical firmly believes in unique business models that suit the growth of partners.